Creation and test of a questionnaire for self-assessment of melanoma risk factors

European Journal of Cancer Prevention

Volumn 19, Issue 1, 2010, Pages 48-54

  Quéreux, Gaëlle ^a   Nguyen, Jean Michel ^b   Volteau, Christelle ^a   Lequeux, Yves ^a   Dréno, Brigitte ^a  

^a NANTES UNIVERSITY HOSPITAL   (France)

^b PIMESP   (France)

Author keywords

Melanoma; Prevention; Risk factor; Risk prediction tool; Screening; Self assessment

Indexed keywords

ACCURACY; ADULT; AGED; ARTICLE; CANCER RISK; CONSULTATION; FEMALE; GENERAL PRACTITIONER; HIGH RISK POPULATION; HUMAN; INFANCY; MAJOR CLINICAL STUDY; MALE; MELANOMA; NEVUS; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SELF EVALUATION; SKIN CANCER; SUNBURN; VALIDITY;

ADOLESCENT; ADULT; AGED; FEASIBILITY STUDIES; FEMALE; HUMANS; MALE; MELANOMA; MIDDLE AGED; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; SELF CARE; SENSITIVITY AND SPECIFICITY; SKIN NEOPLASMS; YOUNG ADULT;

EID: 75149172344     PISSN: 09598278     EISSN: None     Source Type: Journal    
DOI: 10.1097/CEJ.0b013e328333d113     Document Type: Article

References (34)

1. Buttner P, Garbe C, Bertz J, Burg G, d'Hoedt B, Drepper H, et al. (1995). Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer 7 5:2499-2506.
2. Carli P, De Giorgi V, Nardini P, Mannone F, Palli D, Giannotti B (2002). Melanoma detection rate and concordance between self-skin examination and clinical evaluation in patients attending a pigmented lesion clinic in Italy. Br J Dermatol 146:261-266.
3. Coory M, Baade P, Aitken J, Smithers M, McLeod GR, Ring I (2006). Trends for in situ and invasive melanoma in Queensland, Australia, 1982-2002. Cancer Causes Control 17:21-27.
4. De Vries E, Coebergh JW (2005). Melanoma incidence has risen in Europe. BMJ 3 31:698.
5. Downing A, Yu XQ, Newton-Bishop J, Forman D (2008). Trends in prognostic factors and survival from cutaneous melanoma in Yorkshire, UK and New South Wales, Australia between 1993 and 2003. Int J Cancer 123:861-866.
6. Elwood JM (1996). Melanoma and sun exposure. Semin Oncol 23:650-666.
7. Fitzpatrick TB (1988). The validity and practicality of sun-reactive skin types I through VI. Arch Dermatol 124:869-871.
8. Fry A, Verne J (2003). Preventing skin cancer. BMJ 326:114-115.
9. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Abeni D, Boyle P, et al. (2005a). Meta-analysis of risk factors for cutaneous melanoma: I. Common and atypical naevi. Eur J Cancer 41:28-44.
10. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P, Melchi CF (2005b). Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 41:45-60.
11. Gandini S, Sera F, Cattaruzza MS, Pasquini P, Zanetti R, Masini C, et al. (2005c). Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors. Eur J Cancer 41:2040-2059.
12. Geller AC, Emmons KM, Brooks DR, Powers C, Zhang Z, Koh HK, et al. (2006). A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer 107:806-814.
13. Grange F (2005). Epidemiology of cutaneous melanoma: descriptive data in France and Europe. Ann Dermatol Venereol 132:975-982.
14. Grob JJ, Gouvernet J, Aymar D, Mostaque A, Romano MH, Collet AM, et al. (1990). Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 6 6:387-395.
15. Harbauer A, Binder M, Pehamberger H, Wolff K, Kittler H (2003). Validity of an unsupervised self-administered questionnaire for self-assessment of melanoma risk. Melanoma Res 13:537-542.
16. Helfand M, Mahon SM, Eden KB, Frame PS, Orleans CT (2001). Screening for skin cancer. Am J Prev Med 20:47-58.
17. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ (1995a). Cutaneous melanoma in women. I. Exposure to sunlight, ability to tan, and other risk factors related to ultraviolet light. Am J Epidemiol 141:923-933.
18. Holly EA, Aston DA, Cress RD, Ahn DK, Kristiansen JJ (1995b). Cutaneous melanoma in women. II. Phenotypic characteristics and other host-related factors. Am J Epidemiol 141:934-942.
19. Jackson A, Wilkinson C, Ranger M, Pill R, August P (1998). Can primary prevention or selective screening for melanoma be more precisely targeted through general practice? A prospective study to validate a self administered risk score. BMJ 316:34-38. discussion 38-39.
20. Jemal A, Devesa SS, Hartge P, Tucker MA (2001). Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 9 3:678-683.
21. Landi MT, Baccarelli A, Calista D, Pesatori A, Fears T, Tucker MA (2001). Combined risk factors for melanoma in a Mediterranean population. Br J Cancer 85:1304-1310.
22. Lawson DD, Moore DH 2nd, Schneider JS, Sagebiel RW (1994). Nevus counting as a risk factor for melanoma: comparison of self-count with count by physician. J Am Acad Dermatol 31:438-444.
23. Little P, Keefe M, White J (1995). Self screening for risk of melanoma: validity of self mole counting by patients in a single general practice. BMJ 3 10:912-916.
24. Loria D, Matos E (2001). Risk factors for cutaneous melanoma: a case-control study in Argentina. Int J Dermatol 40:108-114.
25. MacKie RM, Freudenberger T, Aitchison TC (1989). Personal risk-factor chart for cutaneous melanoma. Lancet 2:487-490.
26. Masri GD, Clark WH Jr, Guerry Dt, Halpern A, Thompson CJ, Elder DE (1990). Screening and surveillance of patients at high risk for malignant melanoma result in detection of earlier disease. J Am Acad Dermatol 22:1042-1048.
27. McKinnon JG, Yu XQ, McCarthy WH, Thompson JF (2003). Prognosis for patients with thin cutaneous melanoma: long-term survival data from New South Wales Central Cancer Registry and the Sydney Melanoma Unit. Cancer 98:1223-1231.
28. Melia J, Harland C, Moss S, Eiser JR, Pendry L (2000). Feasibility of targeted early detection for melanoma: a population-based screening study. Br J Cancer 82:1605-1609.
29. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Menegoz F, et al. (2003). Cancer incidence and mortality in France over the period 1 978-2000. Rev Epidemiol Sante Publique 51:3-30.
30. Richtig E, Santigli E, Fink-Puches R, Weger W, Hofmann-Wellenhof R (2008). Assessing melanoma risk factors: how closely do patients and doctors agree? Public Health 122:1433-1439.
31. US Preventive Services Task Force (2001). Screening for skin cancer: recommendations and rationale. Am J Prev Med 20:44-46.
32. Williams HA, Fritschi L, Beauchamp C, Katris P (2006). Evaluating the usefulness of self-reported risk factors in a skin cancer screening program. Melanoma Res 16:341-345.
33. Wilson JM, Jungner YG (1968). Principles and practice of mass screening for disease. Bol Oficina Sanit Panam 65:281-393.
34. Wolfe JT (1999). The role of screening in the management of skin cancer. Curr Opin Oncol 11:123-128.